The androgen receptor (AR) is a transcription factor belonging to the nuclear hormone family of receptors and continues as the primary target for PC drug development as its role in the maintenance of PC tumors in all stages of progression is well-documented [2]. The gene discussed is AR; the disease is pachyonychia congenita.